Observational studyInternal medicine (Tokyo, Japan)2026

Adding Semaglutide to SGLT2 Inhibitors Reduces Liver Enzymes in Patients with Type 2 Diabetes Complicated by Metabolic Dysfunction Associated Steatotic Liver Disease: A Retrospective Observational Study.

Kanako Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.